Literature DB >> 13873037

Therapy of acute leukaemia: comparison of initial treatment with 6-mercap-topurine alone and in combination with steroids.

J M BRIDGES, D M HAYES, M G NELSON.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES/therapy; LEUKEMIA/therapy; MERCAPTOPURINE/therapy

Mesh：

Substances：

Year:  1962        PMID： 13873037      PMCID： PMC2071212          DOI： 10.1038/bjc.1962.5

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Clinical experience with 6-mercaptopurine in human neoplasia.

Authors:  B E HALL; M D RICHARDS; F M WILLETT; T V FEICHTMEIR
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

2.  Statistical analysis of clinical results from 6-mercaptopurine.

Authors:  I D BROSS
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

3.  The influence of chemotherapy on survival in acute leukemia; comparison of cases treated during 1954 to 1957 with those treated during 1947 to 1954.

Authors:  A HAUT; S J ALTMAN; M M WINTROBE; G E CARTWRIGHT
Journal:  Blood       Date:  1959-07       Impact factor: 22.113

4.  Acute leukaemia in adults treated with 6-mercaptopurine.

Authors:  D M WHITELAW; R G MOFFAT; W H PERRY; R E BECK
Journal:  Can Med Assoc J       Date:  1956-03-15       Impact factor: 8.262

5.  Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases.

Authors:  J H BURCHENAL; M L MURPHY; R R ELLISON; M P SYKES; T C TAN; L A LEONE; D A KARNOFSKY; L F CRAVER; H W DARGEON; C P RHOADS
Journal:  Blood       Date:  1953-11       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.